advertisement

---

Zhou Y 10

Showing records 1 to 10 | Display all abstracts from Zhou Y

84587 Medium-term clinical outcomes following Xen45 device implantation
Fernández-García A
International Ophthalmology 2020; 40: 709-715

---

85051 Vps35 Deficiency Impairs Cdk5/p35 Degradation and Promotes the Hyperphosphorylation of Tau Protein in Retinal Ganglion Cells
Gao L; Xiao H
Investigative Ophthalmology and Visual Science 2020; 61: 1

---

84587 Medium-term clinical outcomes following Xen45 device implantation
Zhou Y
International Ophthalmology 2020; 40: 709-715

---

85051 Vps35 Deficiency Impairs Cdk5/p35 Degradation and Promotes the Hyperphosphorylation of Tau Protein in Retinal Ganglion Cells
Ai LQ
Investigative Ophthalmology and Visual Science 2020; 61: 1

---

84587 Medium-term clinical outcomes following Xen45 device implantation
García-Alonso M; Andrango HD
International Ophthalmology 2020; 40: 709-715

---

85051 Vps35 Deficiency Impairs Cdk5/p35 Degradation and Promotes the Hyperphosphorylation of Tau Protein in Retinal Ganglion Cells
Chen C; Lin S
Investigative Ophthalmology and Visual Science 2020; 61: 1

---

84587 Medium-term clinical outcomes following Xen45 device implantation
Poyales F
International Ophthalmology 2020; 40: 709-715

---

85051 Vps35 Deficiency Impairs Cdk5/p35 Degradation and Promotes the Hyperphosphorylation of Tau Protein in Retinal Ganglion Cells
Zhou Y
Investigative Ophthalmology and Visual Science 2020; 61: 1

---

84587 Medium-term clinical outcomes following Xen45 device implantation
Garzón N
International Ophthalmology 2020; 40: 709-715

---

85051 Vps35 Deficiency Impairs Cdk5/p35 Degradation and Promotes the Hyperphosphorylation of Tau Protein in Retinal Ganglion Cells
Ye J; Liu W
Investigative Ophthalmology and Visual Science 2020; 61: 1

---